Inventor

Paul D. Rubin

Inventor

Sudbury, MA, US

Overview

1999–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 38 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes41%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%

C07DHeterocyclic compounds12%

C07BGeneral methods of organic chemistry6%

C07CAcyclic or carbocyclic compounds2%

C07KPeptides2%

PatentTitleYear

10,711,067Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery2020 10,253,101Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia2019 8,404,715'Methods and compositions using racemic, (R)-, and (S)-fexofenadine in combination with leukotriene inhibitors'2013 7,064,138'Methods for treating irritable bowel syndrome using optically pure (-) norcisapride'2006 7,030,142'Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites'2006 6,946,464'Methods of treating and preventing a convulsive state'2005 6,835,740'Methods for treating sleep apnea and sleep induced apnea using optically pure () norcisapride'2004 6,790,849'Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants'2004 6,649,183'Methods for treating apnea and apnea disorders using optically pure R() ondansetron'2003 6,620,851'Methods for the treatment of neuropathic pain and other disorders using R()-ketoprofen'2003 6,586,437'(S)-hydroxynefazodone antipsychotic therapy'2003 6,559,165'Methods for treating bulimia using optically pure () norcisapride'2003 6,552,045'Methods and compositions using () norcisapride in combination with proton pump inhibitors or H2 receptor antagonists'2003 6,548,518'Methods of treating gastro-esophogeal reflux disease using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists'2003 6,548,082'Methods for treating apnea and apnea disorders using optically pure R() ondansetron'2003 6,509,353'Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors'2003 6,506,753'Methods of making and using N-desmethylzopiclone'2003 6,495,605'Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure ()-bupropion'2002 6,469,008'(R)-hydroxynefazodone antipsychotic therapy'2002 6,465,470'R-hydroxynefazodone'2002 6,465,469'S-hydroxynefazodone'2002 6,458,374'Methods and compositions for treating chronic disorders using optically pure ()-bupropion'2002 6,458,791'Methods of treating muscle spasms using N-desmethylzopiclone'2002 6,384,037'R-hydroxynefazodone'2002 6,384,038'Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants'2002 6,372,197'Methods and compositions using norastemizole in combination with leukotriene inhibitors'2002 6,369,079'Methods for treating irritable bowel syndrome using optically pure () norcisapride'2002 6,362,227'Methods for the treatment of tinnitus and other disorders using R()ketoptofen'2002 6,362,202'Methods and compositions using () norcisapride in combination with proton pump inhibitors or H2 receptor antagonists'2002 6,353,005'Method and compositions using () norcisapride in combination with proton pump inhibitors or H2 receptor antagonist'2002 6,339,086'Methods of making and using N-desmethylzopiclone'2002 6,248,308'Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma'2001 6,194,431'Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors'2001 6,174,902'R-rabeprazole compositions and methods'2001 6,054,463'Methods for treating dermatitis using descarboethoxyloratadine'2000 6,048,879'Methods for treating apnea, apnea disorders, bulimia, and other disorders using optically pure (+) norcisapride'2000 5,962,464'Methods and compositions for treating allergic asthma using descarboethoxyloratadine'1999 5,900,421'Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2006Patents assigned to SEPRACOR INC (33)· patent assignee history

1999–2013Based in Sudbury, MA, US· patent location history

2002Patents assigned to SWPRACOR INC (1)· patent assignee history

2013Patents assigned to RUBIN PAUL D (1)· patent assignee history

2013Patents assigned to SUNOVION PHARMACEUTICALS INC (1)· patent assignee history

2019–2020Patents assigned to XOMA US LLC (2)· patent assignee history

2019–2020Based in San Francisco, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
SEPRACOR INC	33	1999–2006
XOMA US LLC	2	2019–2020
RUBIN PAUL Dself	1	2013
SUNOVION PHARMACEUTICALS INC	1	2013
SWPRACOR INC	1	2002

Locations

Location	Patents	Span
Sudbury, Massachusetts, US	36	1999–2013
San Francisco, California, US	2	2019–2020